China FDA: Unannounced inspections are around the corner

China's version of the FDA, or CFDA, announced that it will begin conducting unannounced inspections of medical device companies' manufacturing and development efforts starting Sept. 1, as it looks to step up its oversight of the industry. That means that violations of China's product quality regulations, poor adverse event reporting or complaints of product quality or product safety could trigger an inspection. The inspections could lead to warning letters, investigations or device recalls. More | Here's the official order from the CFDA (in Chinese)

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.